Combination use of ranolazine with dofetilide for the maintenance of atrial fibrillation.
University of the Pacific, Thomas J Long School of Pharmacy and Health Sciences, Stockton, CA, United States; David Grant USAF Medical Center, Heart Lung and Vascular Department, Travis AFB, CA, United States. Electronic address: sshah@pacific.edu.
Sachin A
SA
Shah
University of the Pacific, Thomas J Long School of Pharmacy and Health Sciences, Stockton, CA, United States.
Gregory
G
Koyama
University of the Pacific, Thomas J Long School of Pharmacy and Health Sciences, Stockton, CA, United States.
Daniel
D
Da Costa
David Grant USAF Medical Center, Heart Lung and Vascular Department, Travis AFB, CA, United States.
Peichun
P
McGregor
David Grant USAF Medical Center, Heart Lung and Vascular Department, Travis AFB, CA, United States.
Mark
M
Kolasa
D000083:Acetanilides / Q000008:administration & dosage*; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010627:Phenethylamines / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage*; D000069458:Ranolazine; D026941:Sodium Channel Blockers; D013449:Sulfonamides / Q000008:administration & dosage*
D000083:Acetanilides; D000889:Anti-Arrhythmia Agents; D004791:Enzyme Inhibitors; D010627:Phenethylamines; D010879:Piperazines; D026941:Sodium Channel Blockers; D013449:Sulfonamides; D000069458:Ranolazine; C063533:dofetilide
Atrial Fibrillation; Dofetilide; Ranolazine